Following a difficult 2014, Consort Medical (CSRT) saw its share price stage a recovery in December. That may explain why chief executive Jonathan Glenn has seen fit to realise some value.
Mr Glenn offloaded 42,700 shares from his own holdings and 24,300 shares on behalf of his wife, Janis Glenn. Both sales were made at 845p, netting Mr Glenn £360,815 and his wife £205,335. This leaves the couple in control of 0.17 per cent of the company.
There's no update yet on a potential launch date for the group's hotly-anticipated nicotine replacement product, which was given market clearance by authorities last September. The imitation cigarette was developed by Kind Consumer, and will be commercialised by Nicoventures, a subsidiary of British American Tobacco (BATS). Consort's core drug-delivery device business Bespak will manufacture the product.
It's still too early to judge the success of last year’s Aesica acquisition. But as a contract business Aesica should improve the visibility of Consort's revenue stream, and analysts still believe it will boost earnings by 10 to 14 per cent come 2016. It could also help restore company margins to their historic level of around 15 per cent.
Buys | |||||||
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
Aberdeen New Dawn | Susie Rippingall | 06 Jan 15 | 12,500 | 177.78 | 22,223 | 12,500 | 0.010 |
Alliance Trust | Karin Forseke (ch) | 05 Jan 15 | 333 | 480 | 1,598 | 102,332 | 0.018 |
Alliance Trust | J Hylands | 05 Jan 15 | 412 | 480 | 1,978 | 84,893 | 0.015 |
Alliance Trust | Katherine Garrett-Cox (ce) | 05 Jan 15 | 1,148 | 480 | 5,510 | 608,011 | 0.110 |
Alliance Trust ♥ | Katherine Garrett-Cox (ce) | 05 Jan 15 | 449 | 480 | 2,155 | 608,371 | 0.110 |
Alliance Trust Ω | Katherine Garrett-Cox (ce) | 05 Jan 15 | 811 | 480 | 3,893 | 606,863 | 0.110 |
Ariana Resources | William Payne (cfo) | 07 Jan 15 | 300,000 | 0.87 | 2,610 | 3,968,289 | 0.614 |
Ariana Resources | Michael de Villiers (ch & cs) | 07 Jan 15 | 500,000 | 0.87 | 4,350 | 14,300,000 | 2.214 |
BlackRock Commodities Income | EW Warner | 07 Jan 15 | 12,000 | 88.6 | 10,632 | 32,000 | 0.030 |
British Assets Trust | James Grover | 05 Jan 15 | 7,500 | 129.87 | 9,740 | 27,500 | 0.010 |
Castings | GB Wainwright | 06 Jan 15 | 5,000 | 399.5 | 19,975 | 101,261 | 0.232 |
Digital Barriers * | Bernie Waldron | 06 Jan 15 | 54,054 | 37 | 20,000 | 113,536 | 0.134 |
Digital Barriers * | Sharon Cooper (fd) | 06 Jan 15 | 67,567 | 37 | 25,000 | 67,567 | 0.080 |
Digital Barriers * | Colin Evans (coo) | 06 Jan 15 | 81,081 | 37 | 30,000 | 774,920 | 0.917 |
Digital Barriers * | Dr Tom Black (ch) | 06 Jan 15 | 540,540 | 37 | 200,000 | 4,784,968 | 5.663 |
Digital Barriers * | Paul Taylor | 06 Jan 15 | 27,027 | 37 | 10,000 | 75,794 | 0.090 |
Digital Barriers * | Zak Doffman (ce) | 06 Jan 15 | 67,567 | 37 | 25,000 | 732,644 | 0.867 |
Dods | Cheryl Jones (ch) | 06 Jan 15 | 2,000,000 | 7 | 140,000 | 4,825,000 | 1.420 |
Finsbury Growth & Income Trust | JP Allard | 05 Jan 15 | 678 | 539.59 | 3,658 | 30,953 | 0.030 |
KBC Advanced Technologies | Ian Godden (ch) | 05 Jan 15 | 25,000 | 89.5 | 22,375 | 226,000 | 0.277 |
KBC Advanced Technologies | Ian Godden (ch) | 07 Jan 15 | 50,000 | 90 | 45,000 | 276,000 | 0.339 |
Legal & General | Carolyn Bradley | 02 Jan 15 | 597 | 246 | 1,469 | 597 | <0.001 |
Legal & General | Lizabeth Zlatkus | 02 Jan 15 | 727 | 246 | 1,788 | 9,629 | <0.001 |
Legal & General | Richard Meddings | 02 Jan 15 | 727 | 246 | 1,788 | 727 | <0.001 |
Legal & General | John Stewart (ch) | 02 Jan 15 | 3,146 | 246 | 7,739 | 317,878 | <0.001 |
Legal & General | Lindsay Tomlinson OBE | 02 Jan 15 | 1,021 | 246 | 2,512 | 20,781 | <0.001 |
Legal & General | Olaf Swantee | 02 Jan 15 | 1,371 | 246 | 3,373 | 7,095 | <0.001 |
Legal & General | Rudy Markham | 02 Jan 15 | 1,157 | 246 | 2,846 | 243,843 | 0.004 |
Legal & General | Stuart Popham | 02 Jan 15 | 664 | 246 | 1,633 | 49,183 | 0.001 |
Nature | Nigel Sandy (ch) | 05 Jan 15 | 10,000 | 12.8 | 1,280 | 408,000 | 0.515 |
Patagonia Gold | William Humphries (ce) | 06 Jan 15 | 201,512 | 3.65 | 7,355 | 31,094,211 | 2.971 |
Rolls-Royce Holdings | Ruth Cairnie | 07 Jan 15 | 226 | 859 | 1,941 | 766 | <0.001 |
Rolls-Royce Holdings | Ian Davis (ch) | 07 Jan 15 | 230 | 859 | 1,976 | 19,257 | 0.001 |
Rolls-Royce Holdings | John Neill | 07 Jan 15 | 370 | 859 | 3,178 | 45,289 | 0.002 |
Rolls-Royce Holdings | Sir Frank Chapman | 07 Jan 15 | 461 | 859 | 3,960 | 9,596 | 0.001 |
Schroder UK Growth Fund Ω | Carolan Dobson | 06 Jan 15 | 15,960 | 155.77 | 24,861 | 15,960 | 0.010 |
Seneca Global Income & Growth Trust | J McCulloch | 05 Jan 15 | 15,000 | 135 | 20,250 | 15,000 | 0.038 |
Servoca | Andy Church (ce) | 02 Jan 15 | 20,000 | 17.9 | 3,580 | 6,756,613 | 5.405 |
Servoca | Andy Church (ce) | 02 Jan 15 | 30,000 | 17.4 | 5,220 | 6,736,613 | 5.389 |
Servoca | Andy Church (ce) | 06 Jan 15 | 57,800 | 17.7 | 10,231 | 6,814,413 | 5.427 |
Treatt | Richard Hope (fd) | 02 Jan 15 | 1,076 | 140 | 1,506 | 152,026 | 0.290 |
Utilico Investments | G Cole | 07 Jan 15 | 6,592 | 113 | 7,449 | 6,592 | 0.007 |
Utilico Investments | PI Burrows | 07 Jan 15 | 6,592 | 113 | 7,449 | 70,170 | 0.071 |
ValiRx * | Gerry Desler (fd) | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 17,733,921 | 0.531 |
ValiRx * | Seppo Makinen | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 6,273,387 | 0.188 |
ValiRx * | Dr George Morris (coo) | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 23,535,993 | 0.704 |
ValiRx * | Dr Satu Vainikka (ce) | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 28,113,714 | 0.841 |
ValiRx * | Kevin Alexander | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 13,034,843 | 0.390 |
ValiRx * | Oliver de Giorgio-Miller (ch) | 06 Jan 15 | 5,000,000 | 0.2 | 10,000 | 7,444,411 | 0.223 |
Whitbread | Nicholas Cadbury (fd) | 06 Jan 15 | 325 | 4,658.13 | 15,139 | 1,825 | 0.001 |
Sells | |||||||
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
Avon Rubber | Stella Pirie | 02 Jan 15 | 10,000 | 757.5 | 75,750 | 42,000 | 0.135 |
Cenkos Securities * † | Jeremy Allen | 07 Jan 15 | 145,959 | 188 | 274,403 | 1,481,957 | 2.326 |
Cenkos Securities * † | Jim Durkin (ce) | 07 Jan 15 | 514,417 | 188 | 967,104 | 5,212,299 | 8.181 |
Cenkos Securities * † | Joe Nally | 07 Jan 15 | 112,367 | 188 | 211,250 | 1,141,849 | 1.792 |
Cenkos Securities * † | Paul Hodges | 07 Jan 15 | 529,480 | 188 | 995,422 | 5,364,486 | 8.420 |
Consort Medical | Jonathan Glenn (ce) | 06 Jan 15 | 42,700 | 845 | 360,815 | 107,847 | 0.220 |
Consort Medical ♥ | Jonathan Glenn (ce) | 06 Jan 15 | 24,300 | 845 | 205,335 | 83,547 | 0.170 |
CVS | Simon Innes (ce) | 06 Jan 15 | 9,430 | 446 | 42,058 | 546,475 | 0.928 |
Gama Aviation | Nigel Payne | 05 Jan 15 | 32,899 | 345 | 113,502 | 0 | 0.000 |
Kingfisher | Kevin O'Byrne | 05 Jan 15 | 26,000 | 337.13 | 87,654 | 410,698 | 0.017 |
Mid Wynd International Inv Trust | Russel Napier | 06 Jan 15 | 9,500 | 301 | 28,595 | 264,325 | 1.112 |
Univision Engineering | Stephen Koo (ch) | 06 Jan 15 | 1,500,000 | 0.97 | 14,550 | 279,703,700 | 72.901 |
*Placing/tender/open offer ♥Spouse/connected party ΩIsa/Sipp †Sold under tender offer |